ISSN 0393-3733 Mensile

Poste Italiane SpA

Sped. in abbonamento

postale - D.L. 353/2003

(conv. in L. 27/02/2004 n.46)

art. 1, comma 1, DCB Milano

1

febbraio 2015

Terapie avanzate

L’Italia giocherà

questa partita?

Medicinali

pediatrici

Uno sviluppo

tutto dedicato

ai piccoli

Dynamic Future.

Reliable Partnership.

The Aenova Group is Europe’s leading contract development and

manufacturing organization for the pharmaceutical and healthcare industry.

Over the horizon

Una farmaceutica

in evoluzione

Assobiomedica

Al comparto

serve riqualificare

il mercato interno

The full-service portfolio of the

Aenova Group covers:

• Galenical and analytical development

• Optimization of formulation concepts

• Manufacturing and packaging across

all main dosage forms

• Support for the certification process

Our facilities are compliant with cGMP and standards of international health authorities, including the US-FDA, TGA and ANVISA.

Members of the Aenova Group

C.P.M. • Dragenopharm • EVP • Haupt Pharma • Swiss Caps • SwissCo • Temmler

Apart from conventional manufacturing,

Aenova offers specialized capacities for:

• High potent oral and sterile dosage forms

• Beta Lactam oral and sterile dosage forms

• Aseptic manufacturing and Lyophilization

• Aqueous and organic granulation

• Aqueous and organic coating of pellets and

tablets

www.aenova-group.com

w

w

w

.

n

o

t

i

z

i

a

r

i

o

c

h

i

m

i

c

o

f

a

r

m

a

c

e

u

t

i

c

o

.

i

t